These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8645677

  • 1. A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours.
    Finlay PM, Richardson MD, Robertson AG.
    Br J Oral Maxillofac Surg; 1996 Feb; 34(1):23-5. PubMed ID: 8645677
    [Abstract] [Full Text] [Related]

  • 2. A comparison of fluconazole oral suspension and amphotericin B oral suspension in older patients with oropharyngeal candidosis. Multicentre Study Group.
    Taillandier J, Esnault Y, Alemanni M.
    Age Ageing; 2000 Mar; 29(2):117-23. PubMed ID: 10791445
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of the efficacy and safety of fluconazole oral suspension and amphotericin B oral suspension in cancer patients with mucositis.
    Lefebvre JL, Domenge C, Study Group of Mucositis.
    Oral Oncol; 2002 Jun; 38(4):337-42. PubMed ID: 12076696
    [Abstract] [Full Text] [Related]

  • 4. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy.
    Ramirez-Amador V, Silverman S, Mayer P, Tyler M, Quivey J.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Aug; 84(2):149-53. PubMed ID: 9269016
    [Abstract] [Full Text] [Related]

  • 5. Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. Adult AIDS Clinical Trials Group Study Team 295.
    Fichtenbaum CJ, Zackin R, Rajicic N, Powderly WG, Wheat LJ, Zingman BS.
    AIDS; 2000 May 05; 14(7):845-52. PubMed ID: 10839593
    [Abstract] [Full Text] [Related]

  • 6. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA, Skiest DJ, Nieto L, Northland R, Sanne I, Gogate J, Greaves W, Isaacs R.
    Clin Infect Dis; 2006 Apr 15; 42(8):1179-86. PubMed ID: 16575739
    [Abstract] [Full Text] [Related]

  • 7. Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.
    Quereda C, Polanco AM, Giner C, Sánchez-Sousa A, Pereira E, Navas E, Fortún J, Guerrero A, Baquero F.
    Eur J Clin Microbiol Infect Dis; 1996 Jan 15; 15(1):30-7. PubMed ID: 8641300
    [Abstract] [Full Text] [Related]

  • 8. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S, Santos ALS, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S.
    Lett Appl Microbiol; 2018 Oct 15; 67(4):392-399. PubMed ID: 30019443
    [Abstract] [Full Text] [Related]

  • 9. Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.
    Arikan S, Akova M, Hayran M, Ozdemir O, Erman M, Gür D, Unal S.
    Clin Infect Dis; 1998 Apr 15; 26(4):903-8. PubMed ID: 9564473
    [Abstract] [Full Text] [Related]

  • 10. Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer.
    Redding SW, Kirkpatrick WR, Coco BJ, Sadkowski L, Fothergill AW, Rinaldi MG, Eng TY, Patterson TF.
    J Clin Microbiol; 2002 May 15; 40(5):1879-81. PubMed ID: 11980984
    [Abstract] [Full Text] [Related]

  • 11. A comparison of fluconazole and itraconazole in the management of denture stomatitis: a pilot study.
    Cross LJ, Bagg J, Wray D, Aitchison T.
    J Dent; 1998 Nov 15; 26(8):657-64. PubMed ID: 9793287
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prophylactic treatment of mycotic mucositis in radiotherapy of patients with head and neck cancers.
    Koc M, Aktas E.
    Jpn J Clin Oncol; 2003 Feb 15; 33(2):57-60. PubMed ID: 12629054
    [Abstract] [Full Text] [Related]

  • 15. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F, Arzeni D, Del Prete MS, Sinicco A, Falconi Di Francesco L, Pasticci MB, Lamura L, Nuzzo MM, Burzacchini F, Coppola S, Chiodo F, Scalise G.
    J Antimicrob Chemother; 1998 May 15; 41(5):541-8. PubMed ID: 9630407
    [Abstract] [Full Text] [Related]

  • 16. Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
    Petraitis V, Petraitiene R, Groll AH, Sein T, Schaufele RL, Lyman CA, Francesconi A, Bacher J, Piscitelli SC, Walsh TJ.
    Antimicrob Agents Chemother; 2001 Feb 15; 45(2):471-9. PubMed ID: 11158743
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and treatment management of oropharyngeal candidiasis in cancer patients: results of the French CANDIDOSCOPE study.
    Gligorov J, Bastit L, Gervais H, Henni M, Kahila W, Lepille D, Luporsi E, Sasso G, Varette C, Azria D, Candidoscope Study Group.
    Int J Radiat Oncol Biol Phys; 2011 Jun 01; 80(2):532-9. PubMed ID: 20594986
    [Abstract] [Full Text] [Related]

  • 18. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
    Pons V, Greenspan D, Lozada-Nur F, McPhail L, Gallant JE, Tunkel A, Johnson CC, McCarty J, Panzer H, Levenstein M, Barranco A, Green S.
    Clin Infect Dis; 1997 Jun 01; 24(6):1204-7. PubMed ID: 9195083
    [Abstract] [Full Text] [Related]

  • 19. Itraconazole and fluconazole in oropharyngeal candidiasis.
    van der Bijl P, Arendorf TM.
    Ann Dent; 1993 Jun 01; 52(2):12-6. PubMed ID: 8267372
    [Abstract] [Full Text] [Related]

  • 20. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Belazi M, Velegraki A, Koussidou-Eremondi T, Andreadis D, Hini S, Arsenis G, Eliopoulou C, Destouni E, Antoniades D.
    Oral Microbiol Immunol; 2004 Dec 01; 19(6):347-51. PubMed ID: 15491459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.